Should clopidogrel be avoided in a third‑trimester pregnant patient with a large cerebral infarct who is beyond the acute reperfusion window?

Clopidogrel Should Be Avoided in Third-Trimester Pregnancy, Even with Large Infarct

For a third-trimester pregnant patient with a large cerebral infarct beyond the acute reperfusion window, clopidogrel should be avoided and low-dose aspirin (75-162 mg daily) should be used instead for secondary stroke prevention. The size of the infarct does not change this recommendation.

Rationale Based on Guidelines

The AHA/ASA stroke prevention guidelines 1, 2 and Canadian Cardiovascular Society guidelines 3 provide clear direction for antiplatelet therapy in pregnancy:

• For pregnant women with lower-risk conditions (those not requiring anticoagulation in non-pregnant state), the recommendation is UFH or LMWH in the first trimester, followed by low-dose aspirin for the remainder of pregnancy (Class IIb, Level C) 1

• Low-dose aspirin (75-162 mg daily) can be used safely during the second and third trimesters (Class I, Level A) 3

• Clopidogrel should only be used during pregnancy when strictly needed (e.g., after stenting) and for the shortest duration possible 4

Why Clopidogrel Should Be Avoided

Limited Safety Data

The FDA drug label 5 states that while available postmarketing data have not identified drug-associated risks for major birth defects or miscarriage, the data remain limited to case reports over two decades. More importantly:

• Clopidogrel increases maternal bleeding risk during labor and delivery 5
• When possible, discontinue clopidogrel 5-7 days prior to labor, delivery, or neuraxial blockade 5
• The risk of spinal hematoma with neuraxial blockade is significant 5

Aspirin Is Safer and Effective

Low-dose aspirin has been extensively studied in pregnancy with demonstrated safety:

• No increased maternal or fetal bleeding risks 3
• No placental abruption increase 3
• No adverse childhood developmental effects up to 12-18 months 3
• Effective for secondary stroke prevention in non-cardioembolic stroke 6

Clinical Algorithm for This Patient

1. Discontinue clopidogrel immediately if currently prescribed

2. Initiate low-dose aspirin 75-162 mg daily for secondary stroke prevention

3. Continue aspirin through delivery - it is safe in the third trimester

4. Plan delivery timing considering:

   • Aspirin can be continued through labor (unlike clopidogrel)
   • Regional anesthesia is safe with aspirin monotherapy
   • No need for bridging therapy

5. Post-delivery: Resume standard secondary stroke prevention regimen based on stroke mechanism

Important Caveats

The one exception where clopidogrel might be considered is if this patient had recent coronary stenting (within 3 months) requiring dual antiplatelet therapy 4. However, this scenario is not mentioned in your question. For isolated cerebral infarction, even if large, aspirin alone is the appropriate choice in the third trimester.

The ESC pregnancy guidelines 4 explicitly state that clopidogrel should be avoided and used only when "strictly needed" - a large infarct alone does not meet this threshold, as aspirin provides adequate secondary prevention without the added maternal hemorrhagic risks that clopidogrel poses during delivery.

Bottom line: Infarct size does not justify the increased bleeding risk of clopidogrel in the third trimester when aspirin provides effective secondary prevention with superior safety profile.